MCK logo McKesson Corporation +
McKesson Corporation
+

McKesson Corporation (MCK) Business News

Track McKesson Corporation in real time with a live news feed covering McKesson Corporation stock news, official press releases, company announcements, and an archive of historical McKesson Corporation news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

10:00 AM | Wednesday | May 27, 2026

news photo
Loading...

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Read full article redirect
10:00 AM | Wednesday | May 27, 2026

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Read full article arrow
News Thumbnail
10:00 AM | Wednesday | May 27, 2026

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Read full article arrow
News Thumbnail
1:21 PM | Friday | May 22, 2026

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

Zacks Investment Research

McKesson's oncology growth, GLP-1 momentum and RxTS expansion support earnings strength, but pricing reform and margin pressures pose risks.

Read full article arrow
News Thumbnail
10:01 AM | Thursday | May 14, 2026

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read full article arrow
News Thumbnail
3:10 PM | Tuesday | May 12, 2026

McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha

McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Read full article arrow
News Thumbnail
3:09 PM | Monday | May 11, 2026

McKesson Q4 Earnings Call Highlights

MarketBeat

McKesson NYSE: MCK reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and prescription technology businesses, while outlining plans for continued earnings growth in fiscal 2027.

Read full article arrow
News Thumbnail
11:51 AM | Friday | May 8, 2026

MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up

Zacks Investment Research

McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.

Read full article arrow
News Thumbnail
9:01 PM | Thursday | May 7, 2026

McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript

Seeking Alpha

McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript

Read full article arrow
News Thumbnail
7:01 PM | Thursday | May 7, 2026

Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics

Zacks Investment Research

Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read full article arrow
News Thumbnail
6:55 PM | Thursday | May 7, 2026

McKesson (MCK) Surpasses Q4 Earnings Estimates

Zacks Investment Research

McKesson (MCK) came out with quarterly earnings of $11.69 per share, beating the Zacks Consensus Estimate of $11.56 per share. This compares to earnings of $10.12 per share a year ago.

Read full article arrow
News Thumbnail
5:50 PM | Thursday | May 7, 2026

McKesson expects 2027 profit slightly above estimates on drug distribution strength

Reuters

McKesson forecast 2027 profit slightly above Wall Street expectations after beating first-quarter profit estimates ​on Thursday, as the U.S. drug distributor ‌banks on strength in its oncology and specialty drug businesses.

Read full article arrow
News Thumbnail